Stratasys Ltd. (SSYS)

Technology · NMS

USD8.01-0.25% today

Fundamentals

Market capUSD706.67M
Revenue growth (YoY)-2.5%
Profit margin-21.0%
Return on equity-14.3%
52-week rangeUSD7.34 to USD12.81

Valuation and ratings

DCF fair valueUSD9.51
Upside to fair value+18.7%
Analyst target (mean)USD12.33
Analyst rangeUSD11.50 to USD13.50
Analysts covering3
Consensus viewnone
Moat score28/100
Overall rating39/100, Reduce

Fair value: USD9.51 (+18.7%), see how we got there

Stratasys Ltd. trades at USD8.01, which is 19% below the USD9.51 our discounted cash flow model puts on the business. On that measure alone it screens as undervalued, though a DCF is an argument rather than a measurement, and the market is frequently right about why something is cheap.

Our moat model scores it 28 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

SSYS earnings and analyst estimates

Next earnings date7 May 2026
EPS estimate, next yearUSD0.18
Expected EPS growth+50.0%
Expected revenue growth+3.7%

Recommendation mix, 4 analyst ratings

3 buy1 hold0 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About Stratasys Ltd.

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, including polyjet printers, fused deposition modeling (FDM) printers designed for prototyping, manufacturing tools, and production parts; PolyJet printers to print multiple materials including color printing in a single part build; pantone having validated colors, and multiple material properties; TechStyleTM, which allows 3D printing directly on different kinds of fabrics, enabling series productions in the fashion industry; Anatomy, which helps medical device companies optimize design throughout the product lifecycle; GelMatrix resin; TissueMatrix resin; BoneMatrix resin; and Digital Anatomy Creator to create different anatomical structures by customizing specific bio-mechanical properties and color. It also offers GrabCAD software for medical users; J35 Pro 3D an all-in-one, multi material desktop 3D printer; 5 DentaJet and J3 DentaJet for the dental and medical; stereolithography printers; Neo range of industrial stereolithography (SLA) 3D printers; Somos resin; Titanium control software; and Origin P3 printer; Origin 3D printers; SAF printers. In addition, it provides consumables, software, paid parts, and professional services; and prototyping, design, and manufacturing aids and production solutions. Stratasys Ltd. is headquartered in Minnetonka, Minnesota.

Industry: Computer HardwareEmployees: 1,757HQ: United States

SSYS passes 2 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Common questions

Is Stratasys Ltd. (SSYS) undervalued?

Against our discounted cash flow estimate of USD9.51, SSYS at USD8.01 is 19% below fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.

The full research page for SSYS, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.